ArticleJournal of clinical pharmacology2026
Limitations of Subgroup Safety Analyses for Drug-Drug Interaction Evaluation: Insights from the Talazoparib P-gp Inhibitor Case.
Diane Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.